alvaiz

Generic: eltrombopag

Labeler: teva pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name alvaiz
Generic Name eltrombopag
Labeler teva pharmaceuticals, inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

eltrombopag choline 9 mg/1

Manufacturer
Teva Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 0480-3273
Product ID 0480-3273_a573cf28-59db-4cb3-84db-af7b77200b66
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA216774
Listing Expiration 2027-12-31
Marketing Start 2024-02-13

Pharmacologic Class

Classes
breast cancer resistance protein inhibitors [moa] increased megakaryocyte maturation [pe] increased platelet production [pe] organic anion transporting polypeptide 1b1 inhibitors [moa] thrombopoietin receptor agonist [epc] thrombopoietin receptor agonists [moa] ugt1a1 inhibitors [moa] ugt1a3 inhibitors [moa] ugt1a4 inhibitors [moa] ugt1a6 inhibitors [moa] ugt1a9 inhibitors [moa] ugt2b15 inhibitors [moa] ugt2b7 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04803273
Hyphenated Format 0480-3273

Supplemental Identifiers

RxCUI
2675187 2675193 2675195 2675197 2675199 2675201 2675203 2675205
UPC
0304803274560 0304803273563
UNII
F9G8XE24IB

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name alvaiz (source: ndc)
Generic Name eltrombopag (source: ndc)
Application Number NDA216774 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 9 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (0480-3273-56)
source: ndc

Packages (1)

0480-3273-56 30 TABLET, FILM COATED in 1 BOTTLE (0480-3273-56)

Ingredients (1)

eltrombopag choline (9 mg/1)

Linked Drug Pages (1)

ALVAIZ ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a573cf28-59db-4cb3-84db-af7b77200b66", "openfda": {"upc": ["0304803274560", "0304803273563"], "unii": ["F9G8XE24IB"], "rxcui": ["2675187", "2675193", "2675195", "2675197", "2675199", "2675201", "2675203", "2675205"], "spl_set_id": ["ed51e463-7a03-4858-bbd2-882ce4753d5a"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0480-3273-56)", "package_ndc": "0480-3273-56", "marketing_start_date": "20240213"}], "brand_name": "ALVAIZ", "product_id": "0480-3273_a573cf28-59db-4cb3-84db-af7b77200b66", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Thrombopoietin Receptor Agonist [EPC]", "Thrombopoietin Receptor Agonists [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A3 Inhibitors [MoA]", "UGT1A4 Inhibitors [MoA]", "UGT1A6 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B15 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]"], "product_ndc": "0480-3273", "generic_name": "Eltrombopag", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ALVAIZ", "active_ingredients": [{"name": "ELTROMBOPAG CHOLINE", "strength": "9 mg/1"}], "application_number": "NDA216774", "marketing_category": "NDA", "marketing_start_date": "20240213", "listing_expiration_date": "20271231"}